Navigation Links
Ban On Trans Fats Comes Into Effect From July 1

Trans fats are chemically modified fats rich in cholesterol and known to cause heart disease. They are widely used as a substitute for saturated fats in bakery products//, fried foods like chips, salad dressings and other foods since long. Food prepared using trans fats is also believed to have a longer shelf life.

In a mighty effort to fight Obesity, the members of the New York City Board of Health, voted yesterday to ban the use of huge amounts of artificial trans fats in restaurants and bakeries.

Experts believe that eliminating trans fats will not change the taste of foods, but chefs and restaurant owners disagree, saying it will be difficult and more expensive to replicate the taste and texture of some menu items without them.

The health department’s restaurant inspectors will be in charge of enforcing both the trans fat and calorie regulations. Violators would have to face fines greater than $200. The Board of Health also demands that restaurants, especially fast food outlets, display the calorific value of each menu item on display boards.

The restaurant industry is highly agitated and accuses the government of interference into free enterprise and civil liberties.

“This is a misguided attempt at social engineering by a group of physicians who don’t understand the restaurant industry,” said Dan Flesher, a representative of National Restaurant Association. He said the association would challenge one or both measures legally.

Mayor Bloomberg said, “ the city is not going to take away anybody’s ability to go out and have the kind of food they want, in the quantities they want.”

“We are just trying to make food safer,” he added.

Restaurants have time until next July 1 to reduce usage of oils and margarine. Admissible fat level is a half-gram of trans fat per serving.

Posting caloric content also takes effect next July 1, this should not be a matter of co ncern for large chains restaurants with highly standardized menus.

Source-Medindi
PRI
'"/>




Related medicine news :

1. Transdermal HRT not cardioprotective in postmenopausal women with CAD
2. Transdermal HRT not cardioprotective in postmenopausal women with Coronary Artery Disease
3. Stem Cell Transplants May Be Effective For MS Patients
4. Transforming stem cells to lung cells
5. Alternative to blood Transfusions
6. Need for Blood Transfusions reduced
7. Drugs Deter Heart Disease for Transplant Patients
8. Better Drug for Heart Transplant
9. Kidney Failure after Non-Kidney Transplants
10. Measles Risk in Transplant Patients
11. West Nile and Blood Transfusions
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/30/2016)... ... May 30, 2016 , ... "This ... FCPX," said Christina Austin - CEO of Pixel Film Studios. , TransPack ... Cut Pro X. Choose from abstract transitions to more simple wipes with blur ...
(Date:5/29/2016)... ... 2016 , ... Whole Health Supply is happy to announce the favorable reception ... Amazon.com. This new style of nail clipper has a wider jaw opening that is ... and the actual handle is 2.5mm thick to accommodate the cutting force. This is ...
(Date:5/28/2016)... ... May 28, 2016 , ... "Color Grading media can be ... a preset onto their media," said Christina Austin - CEO of Pixel Film Studios. ... quickly and easily add stylish color grades to their footage. A LUT is a ...
(Date:5/27/2016)... , ... May 27, 2016 , ... More than a ... it is not surprising that bariatric surgery has received increased attention in recent years, ... Of course, when it comes to weight loss, most people are familiar with the ...
(Date:5/27/2016)... (PRWEB) , ... May 27, 2016 , ... An influential ... for a third time to shed lights on the variety of topics detailing why ... stories, “Nurse Appreciation” tackles why this career has gone from being in a major ...
Breaking Medicine News(10 mins):
(Date:5/27/2016)... , May 27, 2016 ... innovative biopharmaceutical company focused on late-stage drug development, ... Dexcel Pharma of pivotal batches required for ... Drug Administration (FDA). This follows Kitov,s announcement ... III trial successfully met its primary efficacy endpoint. ...
(Date:5/26/2016)... 2016 TARE (Transarterial Radio-embolization) ... Savings and Overall Decreased Use of Hospital ... international specialist healthcare company, has today announced the ... Meeting of ISPOR (International Society for Pharmacoeconomics and ... (HCC) using yttrium-90 glass microspheres is associated with ...
(Date:5/25/2016)... GERMANTOWN, Maryland , May 25, 2016 ... bedient dringenden Bedarf zur ... QIAGEN N.V. (NASDAQ: QGEN ; Frankfurt ... und Entwicklungsvereinbarung mit Therawis Diagnostics GmbH zur Entwicklung ... zu sein. Ein erstes Projekt wird die Entwicklung ...
Breaking Medicine Technology: